Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Effect of High Protein on Body Composition and Markers of Sarcopenia in Patients With Type 2 Diabetes Mellitus

Authors not listed

National and Kapodistrian University of Athens · 2021

Loss of proteostasis Human Randomized controlled trial

Abstract

This study will investigate the impact of dietary protein intake on progressive muscle loss and functionality (sarcopenia) in older adults with type 2 diabetes mellitus. Sarcopenia is known to have a bidirectional interaction with type 2 diabetes mellitus. Therefore in order to address this bidirectional complication we suggest that an increased intake of dietary protein at 1.5 gr/kg/day (current official recommendation is 0.8 gr/kg/day) could help to treat the sarcopenia, which in turn will help to ameliorate the type 2 diabetes mellitus progression.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-31 MST

Cite this

APA

Anonymous. (2021). The Effect of High Protein on Body Composition and Markers of Sarcopenia in Patients With Type 2 Diabetes Mellitus. <em>National and Kapodistrian University of Athens</em>. https://clinicaltrials.gov/study/NCT05457088

Vancouver

Anonymous. The Effect of High Protein on Body Composition and Markers of Sarcopenia in Patients With Type 2 Diabetes Mellitus. National and Kapodistrian University of Athens. 2021.

BibTeX

@misc{anon2021TheEff, title = {The Effect of High Protein on Body Composition and Markers of Sarcopenia in Patients With Type 2 Diabetes Mellitus}, author = {Anonymous}, journal = {National and Kapodistrian University of Athens}, year = {2021}, }